FolioLanternBeta
BMYBristol Myers Squibb

Michael McMullen

Director at Bristol Myers Squibb, as of Oct 2, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
1K
shares held after the latest filing, Bristol Myers Squibb
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
3
companies filed for

Last filing: Oct 2, 2026.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Bristol Myers Squibb (BMY)DirectorJul 2, 2024Oct 2, 2026
KLA Corporation (KLAC)DirectorJul 26, 2023Nov 7, 2025
Agilent Technologies (A)Former CEO and President, DirectorNov 21, 2007Mar 12, 2024

Also a director at

KLA Corporation (KLAC), Agilent Technologies (A) (no filing in the last 18 months)

Recent filings

The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.